Next Article in Journal
Genetic Polymorphism of CYP2R1, CYP27A1, CYP27B1, and Vitamin D Metabolites Plasma Levels in Patients with Cardiovascular Disease: A Pilot Study
Previous Article in Journal
Association Between Scalp High-Frequency Oscillations and Burden of Amplitudes and Epileptiform Discharges (BASED) Scores in Infantile Epileptic Spasms Syndrome
Previous Article in Special Issue
Decidualized Endometrial Stromal Cells Promote Mitochondrial Beta-Oxidation to Produce the Octanoic Acid Required for Implantation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

LIFR-Mediated ERBB2 Signaling Is Essential for Successful Embryo Implantation in Mice

1
Graduate School of Veterinary Science, Azabu University, Kanagawa 252-5201, Japan
2
Laboratory of Toxicology, School of Veterinary Medicine, Azabu University, Kanagawa 252-5201, Japan
3
Laboratory of Animal Reproduction, School of Veterinary Medicine, Azabu University, Kanagawa 252-5201, Japan
4
Laboratory of Theriogenology, School of Veterinary Medicine, Azabu University, Kanagawa 252-5201, Japan
5
Laboratory of Infectious Diseases, School of Veterinary Medicine, Azabu University, Kanagawa 252-5201, Japan
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Current address: Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8397, Japan.
Biomolecules 2025, 15(5), 698; https://doi.org/10.3390/biom15050698 (registering DOI)
Submission received: 1 April 2025 / Revised: 5 May 2025 / Accepted: 7 May 2025 / Published: 10 May 2025
(This article belongs to the Special Issue Properties and Functions of Endometrial Stromal Cells)

Abstract

:
In eutherian mammals, embryo implantation is a critical process for a successful pregnancy. In mice, the activation of the leukemia inhibitory factor (LIF) receptor–STAT3 signaling axis induces embryo adhesion and decidualization. The LIF receptor is believed to function as a heterodimer composed of LIFR (encoded by Lifr) and GP130 (encoded by Il6st); however, their distinct expression patterns in the uterine epithelium immediately prior to implantation suggest divergent functional roles. In this study, we generated uterine epithelium-specific Lifr knockout (Lifr eKO) mice and conducted a comprehensive gene expression analysis of the endometrium before implantation. We compared these results with those from uterine epithelium-specific Gp130 knockout (Gp130 eKO) mice. Similarly to Gp130 eKO mice, Lifr eKO mice were completely infertile. We identified 299 genes with expression changes greater than twofold following gene deletion; among these, 31 genes were downregulated and 57 genes were upregulated in both eKO models. Many of the downregulated genes were previously implicated in uterine function. Hub gene analysis identified Erbb2 and c-Fos as key regulators in both models. Further experiments using an ERBB2 inhibitor suggested that LIFR–ERBB2-mediated signaling plays a crucial role in embryo implantation.

1. Introduction

Infertility, defined as the inability to conceive after 12 months or more of regular unprotected sexual intercourse, affects millions of individuals worldwide [1]. It is estimated that approximately one in six individuals of reproductive age will experience infertility during their lifetime. Infertility can result from various factors affecting either the male or female reproductive system. Although the development of assisted reproductive technologies has facilitated infertility treatment, expanding access to these treatments is crucial for improving pregnancy rates and creating an optimal environment for conception [2]. In humans, the endometrium remains refractory to embryo implantation throughout most of the menstrual cycle, except during a brief period known as the implantation window. This window is estimated to occur 7 ± 2 days after ovulation, with the day of ovulation designated as day 0 [3,4]. The implantation window is tightly regulated by two key hormones, progesterone (P4) and 17β-estradiol (E2), and their effects have been extensively studied using human tissues, cultured cells, and animal models [5,6].
Elucidating the mechanisms underlying embryo implantation—the first point of interaction between the mother and the fetus—studies using genetically modified mouse models have been invaluable, leading to the identification of numerous key regulatory factors [6]. In both humans and mice, embryo implantation involves attachment, adhesion, and the invasion of the hatched blastocyst into the receptive endometrium, accompanied by decidualization [7]. Similarly to humans, mice exhibit an implantation window regulated by P4 and E2 [6]. In mice, following mating, the presence of a vaginal plug is designated as gestation day 1 (D1). A transient surge in E2 on D4, in the presence of P4 secreted by the corpus luteum formed after ovulation, establishes the implantation window [8]. In ovariectomized mice, continuous P4 administration allows the embryo to remain in a hatched blastocyst state within the uterus for up to two weeks (delayed implantation). A single E2 injection triggers implantation and decidualization. In 1992, Stewart et al. demonstrated that female mice lacking the leukemia inhibitory factor (Lif) gene were infertile [9]. In mice, endometrial Lif expression is induced by nidatory E2, and the administration of the recombinant LIF protein rescues implantation in Lif-deficient mice, highlighting LIF as a crucial regulator of embryo implantation and decidualization [10]. LIF, a member of the interleukin-6 (IL-6) cytokine family, has multiple functions, including the maintenance of embryonic stem cell pluripotency [11]. IL-6 family cytokines share the GP130 (interleukin-6 signal transducer, encoded by Il6st) receptor subunit. LIF signals through a heterodimeric receptor complex composed of the GP130 and LIF receptor (LIFR), leading to the activation of the Janus kinase (JAK)–signal transducer and activator of the transcription 3 (STAT3) signaling pathway [12,13]. In addition to LIF, other IL-6 family cytokines, such as oncostatin M (OSM) and cardiotrophin-1 (CT-1), also bind to the GP130/LIFR complex. Notably, CT-1 administration can induce implantation in delayed-implantation mouse models, similar to LIF, underscoring the critical role of GP130/LIFR signaling in embryo implantation [14].
GP130/LIFR signaling plays a pivotal role in the decidualization of endometrial stromal cells, supporting embryonic invasion and placentation in mice. The significance of GP130/LIFR signaling in the uterine epithelium has been demonstrated through studies using genetically engineered mouse models with uterine epithelium-specific gene deletions. Female mice lacking Stat3 (Stat3 eKO) [15], Gp130 (Gp130 eKO) [16], or Lifr (Lifr eKO) [17,18] exhibit infertility due to implantation failure. Our previous studies showed that Gp130 eKO mice display defective epithelial remodeling, reduced hormone responsiveness, and immune cell infiltration in the endometrium [16]. Although GP130 and LIFR function as heterodimeric receptors, their distinct expression patterns in the endometrium during implantation suggest potential differences in their roles. To further elucidate the commonalities and specificities of GP130 and LIFR signaling in embryo implantation, we analyzed Lifr eKO mice using the comprehensive gene expression profiling of preimplantation uterine tissues. This study identifies the essential signaling pathways involved in embryo implantation and decidualization, providing novel insights into the molecular mechanisms underlying infertility.

2. Materials and Methods

2.1. Animals

All animal procedures were approved by the Ethical Committee for Vertebrate Experiments at Azabu University (ID#200312-24). All experiments were conducted in accordance with the relevant guidelines and regulations, including the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines. The following mouse strains, all aged over seven-week-old, were used in the experiments: LtfiCre/+ mouse <Ltftm1(icre)Tdku/J, JAX: 026030> [19], and Lifrtm1a(EUCOMM)Hmgu (strain ID: EM:06941) mouse purchased from the European Mouse Mutant Archive (EMMA). To obtain the Lifrflox/flox mice, Lifrtm1a(EUCOMM)Hmgu mice were crossed with FLPe transgenic mice <Tg(CAG-flpe)36Ito> (RBRC01834) [20]. FRT-LacZ-neo-FRT cassette was removed, and loxP-flanked exon 4 of the Lifr gene was left in Lifrflox/flox mice. Lifrflox/flox mice were then crossed with LtfiCre/+ mice. Lifrflox/flox mice harboring LtfiCre were used as the uterine epithelial conditional knockout of Lifr (Lifr eKO), and Lifrflox/flox mice were used as the control. The primers used for genotyping were as follows: 5′-GTTTCCTCCTTCTGGGCTCC-3′, 5′-TTTAGTGCCCAGCTTCCCAG-3′ and 5′-CCTGTTGTTCAGCTTGCACC-3′ for LtfiCre; 5′-TGAGAGCACGGAAGCTCTTT-3′ and 5′-ACTGCCCGACAAGGTTTTTA-3′ for Lifrflox. All strains were maintained on the C57BL/6J background purchased from Jackson Laboratory Japan (Kanagawa, Japan) and housed in the barrier facility at Azabu University. All mice were fed ad libitum under controlled light–dark cycles (12 h light/12 h dark) at 23 ± 2 °C. The first day of pregnancy (D1) was designated as the morning when a vaginal plug was observed in the female that had been mated with fertile wild-type males on the previous evening. The implantation sites were visualized by an intravenous injection of 0.1 mL/head of 1% Chicago sky blue 6B (C8679, Sigma-Aldrich, St. Louis, MO, USA) dissolved in saline, as previously described [16]. Artificial decidualization was performed by intraluminal injections of 0.02 mL sesame oil (S3547, Sigma-Aldrich) into one side of the uterine hone after females were mated with a vasectomized male as previously described [16]. Mice were euthanatized by cervical dislocation after receiving a combination anesthetic with 0.75 mg/kg of medetomidine (Meiji Animal Health, Kumamoto, Japan), 4.0 mg/kg of midazolam (Sandoz, Tokyo, Japan), and 5.0 mg/kg of butorphanol (Meiji Animal Health). Uterine tissues were dissected and fixed with 4% paraformaldehyde (PFA) solution in phosphate-buffered saline (PBS) for histological study and snap-frozen and kept at −80 °C until they were used for RNA extraction.
For drug treatment, tucatinib (1 mg/400 μL/ head, T2346, TargetMol, Boston, MA, USA) or sapitinib (1 mg/400 μL/ head, AZD8931, Selleck Chemicals, Houston, TX, USA), dissolved in 10% dimethyl sulfoxide (D2650, Sigma-Aldrich), 0.5% methylcellulose (M0262, Sigma-Aldrich), and 0.1% polysorbate 80 (P8074, Sigma-Aldrich) in distilled water, was orally administered to female mice on D3 (1800–1900 h) and D4 (0900–1000 h). The uterus was rinsed with saline if no blue band was found after blue dye injection on D5. If no blastocyst was recovered, it was excluded from the analysis.

2.2. Histological Analysis

Fixed uterine tissues were paraffin-embedded, and paraffin sections (6 µm) were stained with hematoxylin and eosin (H&E). The embryo position in the uterine lumen on D5 was determined by dividing the distance from the mesometrial edge to the center of the embryo (referred to as “A” in Figure 1D) by the distance from the mesometrial edge to the anti-mesometrial edge (referred to as “B” in Figure 1D) as described [16].

2.3. Immunostaining

Immunostaining was performed as previously described [16]. Briefly, the paraffin sections (6 µm) were deparaffinized, hydrated, and used for antigen retrieval by autoclaving in 10 mM sodium citrate buffer (pH = 6.0) for 5 min. For immunohistochemistry (IHC), the sections were further incubated in 3% hydrogen peroxide diluted with methanol for 15 min. After blocking with non-specific staining blocking reagent (X0909, Dako, Carpinteria, CA, USA), the slides were incubated with primary antibodies (shown in Table 1) overnight at 4 °C. The same slides were subjected to incubation with the Histofine mouse stain kit (Nichirei Biosciences, Tokyo, Japan) for 1 h. Signals were visualized by 3,3′-diaminobenzidine tetrahydrochloride (DAB) and counterstained with hematoxylin.
For the immunofluorescence (IF) evaluation, the slides were incubated with Alexa Fluor 488-conjugated secondary antibodies (Jackson Immuno Research Laboratories, West Grove, PA, USA) for 1 h and mounted with ProLong Glass Antifade Mountant with NucBlue Stain (P36981, Thermo Fisher Scientific, Waltham, MA, USA). Micrographs were captured by PROVIS AX80 microscopy (Olympus, Tokyo, Japan) or BZ-X700 microscopy (Keyence, Osaka, Japan). All signals were detected under the same lighting conditions for the control and Lifr eKO groups.

2.4. Whole-Mount Staining

The whole-mount staining of the uterine horn was performed as previously described with some modifications [21]. In brief, uteri were fixed in a mixture of dimethyl sulfoxide (DMSO, D5879, Sigma-Aldrich)/methanol (1:4), followed by methanol/PBS containing 1% Triton-X100 (Sigma-Aldrich) (1:1) for 15 min at room temperature (RT), blocked by PBS containing 1% Triton-X100 and 2% skim milk (198-10605, Fujifilm Wako Pure Chemical, Osaka, Japan) for 2 h at RT and incubated with a primary antibody for CDH1 (#3195, Cell signaling technology, Danvers, MA, USA); they were then diluted in a blocking buffer for 5 nights at 4 °C. Uteri were washed with the blocking buffer six times for 30 min each, and then incubated with a secondary antibody diluted in a blocking buffer for 2 nights at 4 °C. Uteri were washed with the blocking buffer six times for 30 min each, and incubated in methanol for 30 min and methanol containing 3% H2O2 overnight. Uteri were washed in methanol and cleaned overnight using BABB (benzyl alcohol/benzyl benzoate, 1:2; benzyl alcohol from Kanto Chemical, Tokyo, Japan; benzyl benzoate from Fujifilm Wako). Images were captured by the Leica TCS SP5 II confocal microscope (Wetzlar, Germany).

2.5. Measurement of Serum Hormone Levels

Blood samples from control and Lifr eKO mice were collected on D4. The serum was separated by centrifugation (4 °C, 6000× g, 7 min) and stored at −80 °C until analysis. The serum concentrations of progesterone (P4) and 17β-estradiol (E2) were measured by the enzyme-linked immunosorbent assay as described previously [22].

2.6. RNA Extraction and RNA Sequence (RNA-Seq)

Total RNA was isolated using the RNeasy plus mini kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. RNA-seq was carried out by Azenta Life Sciences (Burlington, MA, USA). Briefly, 1 μg of total RNA was used following library preparation. The poly(A) mRNA isolation was performed using Oligo(dT) beads. mRNA fragmentation was performed using divalent cations at a high temperature. Priming was performed using Random Primers. First-strand cDNA and second-strand cDNA were synthesized. Purified double-stranded cDNA was then treated to repair both ends and add dA-tailing in one reaction, followed by a T-A ligation to add adaptors to both ends. The size selection of adaptor-ligated DNA was then performed using DNA Clean Beads. Each sample was then amplified by PCR using P5 and P7 primers, and the PCR products were validated. Then, libraries with different indices were multiplexed and loaded on an MGI2000 instrument for sequencing using a 2 × 150 paired-end (PE) configuration according to the manufacturer’s instructions. The FASTQ files were processed for the removal of adaptor sequences, trimmed, and quality-based filtered using fastp v0.23.2 [23]. The trimmed reads had ribosomal RNA removed using SortMeRNA v4.3.6 [24]. The removed reads were mapped onto the reference genome of Mus musculus (GRCm39) using STAR v2.7.10a [25]. Mapped reads were counted using RSEM v1.3.3 [26]. Differential expression analysis was performed in R v4.2.1 (URL https://www.R-project.org/ accessed on 11 January 2022) using the EdgeR v 3.38.4 package [27], and significantly different genes were visualized using an MA plot and heatmap using the gplots v3.1.3 and genefilter v1.78.0 packages. A volcano plot was generated using R with the EnhancedVolcano package (v1.22.0). Gene ontology analysis was performed by ShinyGO 0.77 [28] with DEGs as the input. A Venn diagram was drawn using (https://bioinformatics.psb.ugent.be/webtools/Venn/ accessed on 14 March 2025).

2.7. Statistical Analysis

All of the data are presented as the mean ± standard error of the mean (SEM). Differences in the data were examined with the use of Student’s t-test or the Mann–Whitney U-test. A p-value < 0.05 was considered significant. Embryo implantation rates after ERBB2 inhibitor treatment were tested using the chi-square test.

2.8. Data Availability

The datasets generated and/or analyzed during the current study are available in the GEO repository, accession number GSE293425.

3. Results

3.1. Epithelial-Specific Lifr-Deficient Females Are Infertile

To assess whether uterine epithelium-specific Lifr knockout (Lifr eKO) females exhibit infertility, we examined their reproductive phenotype. All control females gave birth to an average of 6 ± 1 pups per litter (n = 12), whereas Lifr eKO females did not produce any offspring, indicating complete infertility (n = 12) (Figure 1A). To determine whether implantation failure was responsible for this phenotype, we performed blue dye injection assays on day 5 of gestation (D5) to visualize implantation sites. In control females, distinct blue bands indicating successful implantation were observed. In contrast, no implantation sites were detected in Lifr eKO females, and hatched blastocysts were recovered from the uterine lumen (Figure 1B). These results confirm that infertility in Lifr eKO mice is due to implantation failure, with no evidence of decidualization.
Hematoxylin and eosin (HE) staining of D4 uteri revealed that blastocysts were properly positioned on the anti-mesometrial side of the slit-shaped uterine lumen in both control and Lifr eKO females (Figure 1C). Further analysis of D5 uterine sections confirmed that blastocysts in Lifr eKO mice remained on the anti-mesometrial side, similar to controls (Figure 1D,E), and were surrounded by the uterine epithelium (Figure 1F). Whole-mount uterine staining using the epithelial marker CDH1 demonstrated that, in control females, morphological changes associated with decidualization occurred around the blastocyst upon implantation. However, in Lifr eKO females, the slit-like uterine lumen remained unchanged, indicating a lack of decidual response (Figure 1G).
To determine whether hormonal abnormalities contributed to implantation failure, we measured serum levels of P4 and E2 on D4. No significant differences were observed between the control and Lifr eKO females (Figure 1H), suggesting that implantation failure in Lifr eKO mice is not due to hormonal insufficiency.

3.2. No Decidual Reaction in Epithelial-Specific Lifr-Deficient Females

LIF secreted during implantation induces the heterodimerization of LIFR and GP130 in the uterine epithelium, leading to the phosphorylation of STAT3 by Janus tyrosine kinase (JAK) and the subsequent transcriptional activation of target genes [29]. Since Lifr eKO mice lack LIFR in the uterine epithelium, only a few cells exhibited phosphorylated STAT3 (pSTAT3) on D4 (16:00 h) in the luminal epithelium of Lifr eKO mice in this study (Figure 2A). The persistence or cessation of uterine epithelial cell proliferation is closely linked to the success or failure of embryo implantation [30,31]. In Lifr eKO females, epithelial cell proliferation ceased on D4 (16:00 h), similar to the controls (Figure 2B), which is consistent with previous findings [17]. An analysis of steroid hormone receptor expression revealed no significant differences in the levels of estrogen receptor 1 (ESR1) and the progesterone receptor (PGR) on D4 between Lifr eKO and control mice (Figure 2C). However, Lifr eKO females failed to undergo a decidualization response upon implantation. Furthermore, artificial decidualization induced by oil injection into the uterine lumen elicited no response in Lifr eKO mice, as evidenced by the absence of stromal cell differentiation and proliferation (Figure 2D).

3.3. Gene Expression Profiles in the Uterus of Epithelial-Specific Lifr-Deficient Mice During Embryo Implantation

To further investigate the molecular mechanisms underlying infertility in Lifr eKO mice, we performed RNA sequencing (RNA-seq) on preimplantation uterine tissues from Lifr eKO and control mice. A total of 532 differentially expressed genes (DEGs) were identified based on a false discovery rate (FDR) threshold of <0.05, comprising 205 downregulated and 327 upregulated genes in Lifr eKO compared to the controls (Figure 3A, Supplemental Data S1). Among these, 118 genes exhibited at least a twofold decrease in expression, while 181 genes showed a twofold increase (Figure 3B). Functional enrichment analysis of the downregulated genes revealed their association with various cellular processes, including mineral absorption, arginine and proline metabolism, oxidative phosphorylation, and metabolic pathways (Figure 3C). In contrast, upregulated genes were primarily linked to the PI3K-Akt signaling pathway and other metabolic pathways (Figure 3D). Given that we previously performed RNA-seq analysis on Gp130 eKO uteri [16], we examined the overlap between the DEGs identified in Lifr eKO and Gp130 eKO models. We found that 31 genes were commonly downregulated, while 57 genes were commonly upregulated more than twofold in both knockout models (Figure 3E,F, Supplemental Data S2).
The further hub gene analysis of DEGs in Lifr eKO uteri identified Erbb2 as a key regulator. Erbb2 is linked to several factors previously implicated in embryo implantation, including Hif1a, Fgfr2, Areg, Msx1, and Fgf1. Additionally, Fos (c-fos), previously identified as a hub gene in Gp130 eKO uteri, was also highlighted in the present analysis. These findings suggest that a gene network centered on ERBB2 may play a crucial role in embryo implantation and decidualization.

3.4. The Role of Erbb2 in Embryo Implantation

ERBB2 expression was low on D1 but was detected in the uterine epithelium prior to embryo implantation. Following implantation, its expression increased in the luminal epithelium and the primary decidual zone (Figure 4A). In contrast, ERBB2 expression was weak in Lifr eKO uteri, where embryo implantation failed to occur. c-Fos expression was predominantly observed in epithelial cells in both control and Lifr eKO mice on D1 (Figure 4B). In control mice, a marked increase in c-Fos expression was detected from D4 to D5, whereas no such increase was observed in Lifr eKO mice. To investigate whether Erbb2 signaling is directly involved in embryo implantation, we administered two ERBB2 inhibitors, tucatinib, and sapitinib, orally before implantation (Figure 4C). Blue dye injections revealed implantation sites in 100% of the cases treated with tucatinib, similar to the control group. However, in 50% of sapitinib-treated mice, no implantation sites were detected, and blastocysts were recovered instead (Figure 4D,E). These results suggest that the partial inhibition of ERBB2 signaling can lead to implantation failure, highlighting its potential role in successful embryo implantation.

4. Discussion

The present study confirms that the uterine epithelium-specific deletion of the Lifr gene leads to complete infertility. This finding is consistent with a previous report by Fukui et al., who analyzed the phenotype using the same Ltf-Cre knock-in strain [17]. In contrast, Cheng et al. also reported uterine epithelium-specific Lifr deletion; however, incomplete gene deletion in their study resulted in implantation sites in fewer than 40% of the individuals, likely due to the use of a different Ltf-Cre knock-in mouse strain [18]. In the present study, Lifr eKO mice exhibited complete implantation failure, with no decidual response observed. Importantly, at the preimplantation stage (D4, 1600 h), the Lifr eKO uterus was comparable to that of the control group in terms of serum levels of sex steroid hormones, the expression of their receptors, and blastocyst positioning on the anti-mesometrial side of the uterine lumen. However, the absence of STAT3 phosphorylation in the uterine epithelium at the same time point suggests that the presence or absence of activated STAT3 plays a critical role in determining subsequent implantation outcomes. Indeed, in agreement with the findings of Fukui et al., by day 5 of gestation, control females exhibited crypt-like structures at the implantation sites, whereas no such morphological changes were observed in Lifr eKO mice.
In this study, we conducted a comprehensive gene expression analysis of the Lifr eKO uterus on D4 (1600 h) and compared the results with our previous analysis of Gp130 eKO [16]. We identified 299 differentially expressed genes (Lifr eKO: 118 downregulated and 181 upregulated) compared to 484 genes in the Gp130 eKO dataset (146 downregulated and 338 upregulated). Notably, the PI3K-Akt signaling pathway, which plays a crucial role in E2-dependent uterine cell proliferation [32], was altered in both models. While the inhibition of epithelial cell proliferation—a prerequisite for successful embryo implantation [33]—was observed in both Lifr eKO and Gp130 eKO, disruptions in cell signaling pathways may also contribute to the observed implantation failure. A total of 31 genes were commonly downregulated in both Lifr and Gp130 eKO models. Many of these genes are associated with uterine function, including Alox15, which plays a role in lipid metabolism and inflammatory responses and is markedly downregulated in the Gp130 eKO uterine epithelium [16]. Coch has been identified as an early Lif target gene, although its function remains unclear due to the absence of an overt phenotype in null mutants [34]. Several genes implicated in preimplantation processes were also downregulated, such as Slc46a2 and Cyp26a1 [35], Prss23 [36], Pstpip2—which is highly expressed in the epithelium surrounding the implantation site [37]—and Tm4sf4, which is a candidate factor for embryo attachment in humans [38]. Additionally, multiple genes affected by sex steroid hormones were dysregulated, including Trim15 [39] and Entpd3 [40], as well as epithelial-specific factors such as Sprr2a2 [41] and Lgr5 [42]. The anion exchanger Slc26a6, which plays a key role in uterine lumen pH regulation [43], was also downregulated. Mcub, involved in mitochondrial remodeling during stromal cell differentiation [37], and Srd5a1, which facilitates decidualization by converting testosterone into the potent androgen 5α-dihydrotestosterone (DHT) [44], were among the affected genes. Furthermore, Slc22a4 [44] and Gpx2 [45]—both linked to uterine gland development—were also differentially expressed.
In this study, we also identified hub genes associated with expression variation: Erbb2 in Lifr eKO and Fos (c-fos) in Gp130 eKO. A previous study by Kim et al. demonstrated that heparin-binding EGF (HB-EGF), which is essential for uterine epithelial–blastocyst crosstalk, regulates crypt-like space formation via the tyrosine phosphorylation of VANGL2 through the ERBB2/3 pathway [46]. These findings suggest that ERBB2-mediated signaling plays a crucial role in the establishment of embryo implantation. Interestingly, uterine-specific Erbb2-deficient mice exhibited a significant reduction in litter size but did not show complete infertility, whereas epithelial-specific Erbb2 deletion had no effect on fertility. However, the implantation phenotype was more severe in mice who were deficient in both uterine-specific Erbb2 and Erbb3. This suggests functional redundancy between these receptors. The differential effects of ERBB2 inhibition by small-molecule inhibitors further support this notion: while tucatinib, a potent ERBB2 inhibitor [47], did not prevent implantation, sapitinib, which suppresses ERBB2, the epidermal growth factor receptor (EGFR), and ERBB3 [48], leading to implantation failure. These results imply that ERBB3 compensates for ERBB2’s function in uterine epithelial signaling during implantation. Additionally, c-FOS, a nuclear phosphoprotein and transcription factor activated by E2 [49], was expressed in epithelial cells of both control and Lifr eKO uteri on day 1 of gestation. However, by D5, c-FOS expression was observed exclusively in the control epithelium surrounding the embryo, while it was absent in Lifr eKO. Given that the uterine epithelium in direct contact with the blastocyst undergoes collapse to facilitate embryonic invasion, these findings suggest that GP130/LIFR-STAT3-mediated signaling regulates epithelial remodeling via c-FOS expression, which is a process critical for successful implantation.
The loss of epithelial cell polarity, which is required for the acquisition of endometrial receptivity, is recognized in the human endometrium as plasma membrane transformation (PMT) [50]. In mice, epithelial cell polarity is also lost at the time of implantation, followed by trophoblast trophectoderm-mediated entosis, which disrupts the epithelial barrier and allows for interaction with the underlying stroma [51]. It has been shown that LIF signaling plays a critical role in regulating cell polarity through Msx1 and Wnt signaling pathways [52]. Both Lifr eKO and Gp130 eKO mice exhibit complete failure of embryo adhesion, suggesting that the gene set identified in our study may be involved in regulating epithelial polarity. This possibility is further supported by previous findings, which identified that ERBB2 is involved in embryo implantation through VANGL2, a key component of planar cell polarity [46].
The critical role of GP130/LIFR-mediated signaling in the uterine epithelium for processes following blastocyst adhesion is underscored by the fact that female mice lacking uterine epithelium-specific Stat3 [15], Gp130 [16], or Lifr [17,18] all fail to support embryo adhesion. However, as previously reported by us and other research groups, the localization patterns of Gp130 and Lifr during implantation differ significantly despite their presumed function as a heterodimer [16,53]. This suggests that there may be distinct functional roles for each receptor. To address these differences in detail, future studies should involve the analysis of uterine gland epithelial or luminal epithelial-specific gene deletions. For instance, gene deletions targeting the uterine glands can be induced using Foxa2-Cre [54] or Prss29-Cre [55]. However, it is important to note that FOXA2 is widely expressed in endoderm precursors and endoderm-derived organs, while Prss29-Cre has been shown to induce genetic defects after the first pregnancy. Genes highly expressed in the uterine glands, such as Cxcl15 and Rdh1, may serve as potential candidates for the establishment of Cre transgenic or knock-in lines [56].
In humans, efforts have been made to identify markers for assessing endometrial receptivity; however, a comprehensive understanding of embryo–endometrium interactions has not yet been achieved [57]. Notably, the reduced expression of LIFR in the endometrial epithelium has been reported in women with unexplained infertility [58], suggesting that our findings may contribute to the identification of markers for endometrial receptivity in humans.

5. Conclusions

In this study, we identified the key factors involved in regulating embryo implantation by comparing Lifr eKO and Gp130 eKO models (Figure 4F). Further analysis of the similarities and differences between the gene networks in these models is expected to provide a more comprehensive understanding of the underlying mechanisms.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/biom15050698/s1. Data S1: The list of differentially expressed genes (DEGs) in Lifr eKO uteri compared with the control uteri on day 4 (1600 h) of pregnancy; Data S2: Down or upregulated DEGs in both Lifr eKO and Gp130 eKO.

Author Contributions

Conceptualization, J.I.; methodology, J.T., M.N., H.M., N.K., and J.I.; software, H.M.; validation, J.T., Y.K., T.N., and A.K.; formal analysis, H.M.; investigation, J.T., S.N., Y.K., M.O., S.U., S.T., H.S., T.N., A.K., and M.N.; data curation, J.T, S.N., and J.I.; writing—original draft preparation, J.T., S.N., and J.I.; writing—review and editing, J.T, N.K., and J.I.; visualization, J.T., S.N., S.U., and J.I.; supervision, N.K. and J.I.; project administration, J.I.; funding acquisition, J.T., N.K., and J.I. All authors have read and agreed to the published version of the manuscript.

Funding

This study was partially supported by Japan Society for the Promotion of Science (JSPS) KAKENHI, Grant Numbers JP21K09512 and JP24K01950 (to J.T.), JP21K05977 (to N.K.) and JP20H05373 and JP21H02384 (to J.I.).

Institutional Review Board Statement

The animal study protocol was approved by the Ethical Committee for Vertebrate Experiments at Azabu University (ID#200312-24, approved on 7 February 2022). All experiments were conducted in accordance with the relevant guidelines and regulations, including the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines.

Data Availability Statement

The datasets generated and/or analyzed during the current study are available in the GEO repository, accession number GSE293425. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293425 (accessed on 7 May 2025).

Acknowledgments

We thank members of the Laboratory of Animal Reproduction for their technical help. We also thank S.K. Dey (Cincinnati Children’s Hospital Medical Center) for providing LtfiCre mice and W. Muller (University of Manchester) for providing Gp130flox mice. We also thank the Medical Research Council (MRC) for providing Lifrtm1a(EUCOMM)Hmgu. The FLPe transgenic mouse strain (RBRC01834) was provided by RIKEN BRC through the National BioResource Project of the MEXT/AMED, Japan.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
P4Progesterone
E217β-estradiol
LIFLeukemia inhibitory factor

References

  1. Njagi, P.; Groot, W.; Arsenijevic, J.; Dyer, S.; Mburu, G.; Kiarie, J. Financial costs of assisted reproductive technology for patients in low- and middle-income countries: A systematic review. Hum. Reprod. Open 2023, 2023, hoad007. [Google Scholar] [CrossRef] [PubMed]
  2. Sehring, J.; Beltsos, A.; Jeelani, R. Human implantation: The complex interplay between endometrial receptivity, inflammation, and the microbiome. Placenta 2022, 117, 179–186. [Google Scholar] [CrossRef]
  3. Yoshinaga, K. Uterine Receptivity for Blastocyst Implantation. Ann. New York Acad. Sci. 1988, 541, 424–431. [Google Scholar] [CrossRef]
  4. Bazer, F.W.; Wu, G.; Spencer, T.E.; Johnson, G.A.; Burghardt, R.C.; Bayless, K. Novel pathways for implantation and establishment and maintenance of pregnancy in mammals. Mol. Hum. Reprod. 2009, 16, 135–152. [Google Scholar] [CrossRef] [PubMed]
  5. Cha, J.; Sun, X.; Dey, S.K. Mechanisms of implantation: Strategies for successful pregnancy. Nat. Med. 2012, 18, 1754–1767. [Google Scholar] [CrossRef] [PubMed]
  6. Namiki, T.; Ito, J.; Kashiwazaki, N. Molecular mechanisms of embryonic implantation in mammals: Lessons from the gene manipulation of mice. Reprod. Med. Biol. 2018, 17, 331–342. [Google Scholar] [CrossRef] [PubMed]
  7. Wang, H.; Dey, S.K. Roadmap to embryo implantation: Clues from mouse models. Nat. Rev. Genet. 2006, 7, 185–199. [Google Scholar] [CrossRef]
  8. Paria, B.C.; Huet-Hudson, Y.M.; Dey, S.K. Blastocyst’s state of activity determines the “window” of implantation in the receptive mouse uterus. Proc. Natl. Acad. Sci. 1993, 90, 10159–10162. [Google Scholar] [CrossRef]
  9. Stewart, C.L.; Kaspar, P.; Brunet, L.J.; Bhatt, H.; Gadi, I.; Köntgen, F.; Abbondanzo, S.J. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992, 359, 76–79. [Google Scholar] [CrossRef]
  10. Kimber, S.J. Leukaemia inhibitory factor in implantation and uterine biology. Reproduction 2005, 130, 131–145. [Google Scholar] [CrossRef]
  11. Niwa, H.; Burdon, T.; Chambers, I.; Smith, A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 1998, 12, 2048–2060. [Google Scholar] [CrossRef]
  12. Heinrich, P.C.; Behrmann, I.; Haan, S.; Hermanns, H.M.; Müller-Newen, G.; Schaper, F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 2003, 374, 1–20. [Google Scholar] [CrossRef] [PubMed]
  13. Garbers, C.; Hermanns, H.M.; Schaper, F.; Müller-Newen, G.; Grötzinger, J.; Rose-John, S.; Scheller, J. Plasticity and cross-talk of Interleukin 6-type cytokines. Cytokine Growth Factor Rev. 2012, 23, 85–97. [Google Scholar] [CrossRef] [PubMed]
  14. Kobayashi, R.; Terakawa, J.; Kato, Y.; Azimi, S.; Inoue, N.; Ohmori, Y.; Hondo, E. The contribution of leukemia inhibitory factor (LIF) for embryo implantation differs among strains of mice. Immunobiology 2014, 219, 512–521. [Google Scholar] [CrossRef] [PubMed]
  15. Hiraoka, T.; Hirota, Y.; Fukui, Y.; Gebril, M.; Kaku, T.; Aikawa, S.; Hirata, T.; Akaeda, S.; Matsuo, M.; Haraguchi, H.; et al. Differential roles of uterine epithelial and stromal STAT3 coordinate uterine receptivity and embryo attachment. Sci. Rep. 2020, 10, 1–12. [Google Scholar] [CrossRef]
  16. Namiki, T.; Terakawa, J.; Karakama, H.; Noguchi, M.; Murakami, H.; Hasegawa, Y.; Ohara, O.; Daikoku, T.; Ito, J.; Kashiwazaki, N. Uterine epithelial Gp130 orchestrates hormone response and epithelial remodeling for successful embryo attachment in mice. Sci. Rep. 2023, 13, 1–13. [Google Scholar] [CrossRef]
  17. Fukui, Y.; Hirota, Y.; Saito-Fujita, T.; Aikawa, S.; Hiraoka, T.; Kaku, T.; Hirata, T.; Akaeda, S.; Matsuo, M.; Shimizu-Hirota, R.; et al. Uterine Epithelial LIF Receptors Contribute to Implantation Chamber Formation in Blastocyst Attachment. Endocrinology 2021, 162, bqab169. [Google Scholar] [CrossRef]
  18. Cheng, J.; Rosario, G.; Cohen, T.V.; Hu, J.; Stewart, C.L. Tissue-Specific Ablation of the LIF Receptor in the Murine Uterine Epithelium Results in Implantation Failure. Endocrinology 2017, 158, 1916–1928. [Google Scholar] [CrossRef]
  19. Daikoku, T.; Ogawa, Y.; Terakawa, J.; Ogawa, A.; DeFalco, T.; Dey, S.K. Lactoferrin-iCre: A New Mouse Line to Study Uterine Epithelial Gene Function. Endocrinology 2014, 155, 2718–2724. [Google Scholar] [CrossRef]
  20. Kanki, H.; Suzuki, H.; Itohara, S. High-efficiency CAG-FLPe Deleter Mice in C57BL/6J Background. Exp. Anim. 2006, 55, 137–141. [Google Scholar] [CrossRef]
  21. Arora, R.; Fries, A.; Oelerich, K.; Marchuk, K.; Sabeur, K.; Giudice, L.C.; Laird, D.J. Insights from imaging the implanting embryo and the uterine environment in three dimensions. Development 2016, 143, 4749–4754. [Google Scholar] [CrossRef] [PubMed]
  22. Noguchi, M.; Suzuki, T.; Sato, R.; Sasaki, Y.; Kaneko, K. Artificial lactation by exogenous hormone treatment in non-pregnant sows. J. Reprod. Dev. 2020, 66, 453–458. [Google Scholar] [CrossRef] [PubMed]
  23. Chen, S.; Zhou, Y.; Chen, Y.; Gu, J. fastp: An ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 2018, 34, i884–i890. [Google Scholar] [CrossRef]
  24. Kopylova, E.; Noé, L.; Touzet, H. SortMeRNA: Fast and accurate filtering of ribosomal RNAs in metatranscriptomic data. Bioinformatics 2012, 28, 3211–3217. [Google Scholar] [CrossRef] [PubMed]
  25. Dobin, A.; Davis, C.A.; Schlesinger, F.; Drenkow, J.; Zaleski, C.; Jha, S.; Batut, P.; Chaisson, M.; Gingeras, T.R. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 2013, 29, 15–21. [Google Scholar] [CrossRef]
  26. Li, B.; Dewey, C.N. RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 2011, 12, 323. [Google Scholar] [CrossRef]
  27. Robinson, M.D.; McCarthy, D.J.; Smyth, G.K. EdgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010, 26, 139–140. [Google Scholar] [CrossRef]
  28. Ge, S.X.; Jung, D.; Yao, R. ShinyGO: A graphical gene-set enrichment tool for animals and plants. Bioinformatics 2020, 36, 2628–2629. [Google Scholar] [CrossRef]
  29. Cheng, J.-G.; Chen, J.R.; Hernandez, L.; Alvord, W.G.; Stewart, C.L. Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation. Proc. Natl. Acad. Sci. 2001, 98, 8680–8685. [Google Scholar] [CrossRef]
  30. Hantak, A.M.; Bagchi, I.C.; Bagchi, M.K. Role of uterine stromal-epithelial crosstalk in embryo implantation. Int. J. Dev. Biol. 2014, 58, 139–146. [Google Scholar] [CrossRef]
  31. Kobayashi, R.; Terakawa, J.; Omatsu, T.; Hengjan, Y.; Mizutani, T.; Ohmori, Y.; Hondo, E. The Window of Implantation Is Closed by Estrogen via Insulin-Like Growth Factor 1 Pathway. J. Reprod. Infertil. 2017, 18, 231–241. [Google Scholar] [PubMed]
  32. Sirohi, V.K.I.; Medrano, T.; Mesa, A.M.; Kannan, A.; Bagchi, I.C.; Cooke, P.S. Regulation of AKT Signaling in Mouse Uterus. Endocrinology 2021, 163. [Google Scholar] [CrossRef]
  33. Li, Q.; Kannan, A.; DeMayo, F.J.; Lydon, J.P.; Cooke, P.S.; Yamagishi, H.; Srivastava, D.; Bagchi, M.K.; Bagchi, I.C. The Antiproliferative Action of Progesterone in Uterine Epithelium Is Mediated by Hand2. Science 2011, 331, 912–916. [Google Scholar] [CrossRef] [PubMed]
  34. Rodriguez, C.I.; Cheng, J.-G.; Liu, L.; Stewart, C.L. Cochlin, a Secreted von Willebrand Factor Type A Domain-Containing Factor, Is Regulated by Leukemia Inhibitory Factor in the Uterus at the Time of Embryo Implantation. Endocrinology 2004, 145, 1410–1418. [Google Scholar] [CrossRef]
  35. Kelleher, A.M.; Burns, G.W.; Behura, S.; Wu, G.; Spencer, T.E. Uterine glands impact uterine receptivity, luminal fluid homeostasis and blastocyst implantation. Sci. Rep. 2016, 6, 38078. [Google Scholar] [CrossRef]
  36. Diao, H.; Xiao, S.; Li, R.; Zhao, F.; Ye, X. Distinct Spatiotemporal Expression of Serine Proteases Prss23 and Prss35 in Periimplantation Mouse Uterus and Dispensable Function of Prss35 in Fertility. PLoS ONE 2013, 8, e56757. [Google Scholar] [CrossRef]
  37. Chen, Y.; Ni, H.; Ma, X.-H.; Hu, S.-J.; Luan, L.-M.; Ren, G.; Zhao, Y.-C.; Li, S.-J.; Diao, H.-L.; Xu, X.; et al. Global analysis of differential luminal epithelial gene expression at mouse implantation sites. J. Mol. Endocrinol. 2006, 37, 147–161. [Google Scholar] [CrossRef] [PubMed]
  38. Qiao, J.; Wang, L.; Li, R.; Zhang, X. Microarray evaluation of endometrial receptivity in Chinese women with polycystic ovary syndrome. Reprod. Biomed. Online 2008, 17, 425–435. [Google Scholar] [CrossRef]
  39. Wall, E.H.; Hewitt, S.C.; Liu, L.; del Rio, R.; Case, L.K.; Lin, C.; Korach, K.S.; Teuscher, C. Genetic control of estrogen-regulated transcriptional and cellular responses in mouse uterus. FASEB J. 2013, 27, 1874–1886. [Google Scholar] [CrossRef]
  40. Mo, D.; Zeng, Z.; Lin, M.; Hu, K.-L.; Zhou, P.; Liu, Y.; Li, R.; Yang, Y. Expression and Hormonal Regulation of Entpd3 at Various Estrous Cycle Stages in the Mouse Uterus. Reprod. Sci. 2024, 1–9. [Google Scholar] [CrossRef]
  41. Hong, S.H.; Nah, H.Y.; Lee, J.Y.; Lee, Y.J.; Lee, J.W.; Gye, M.C.; Kim, C.H.; Kang, B.M.; Kim, M.K. Estrogen Regulates the Expression of the Small Proline-rich 2 Gene Family in the Mouse Uterus. Mol. Cells 2004, 17, 477–484. [Google Scholar] [CrossRef] [PubMed]
  42. Sun, X.; Jackson, L.; Dey, S.K.; Daikoku, T. In Pursuit of Leucine-Rich Repeat-Containing G Protein-Coupled Receptor-5 Regulation and Function in the Uterus. Endocrinology 2009, 150, 5065–5073. [Google Scholar] [CrossRef]
  43. Chan, H.C.; Sun, X. SLC26 anion exchangers in uterine epithelial cells and spermatozoa: Clues from the past and hints to the future. Cell Biol. Int. 2013, 38, 1–7. [Google Scholar] [CrossRef]
  44. Shaw, I.W.; Kirkwood, P.M.; Rebourcet, D.; Cousins, F.L.; Ainslie, R.J.; Livingstone, D.E.W.; Smith, L.B.; Saunders, P.T.; Gibson, D.A. A role for steroid 5 alpha-reductase 1 in vascular remodeling during endometrial decidualization. Front. Endocrinol. 2022, 13, 1027164. [Google Scholar] [CrossRef]
  45. Krehelova, A.; Kovarikova, V.; Fabian, D.; Solar, P.; Curgali, K.; Neratzakis, I.; Hodorova, I.; Mihalik, J. Glutathione peroxidase 1 and 2 during preimplantation period of pregnancy in mouse. Bratisl. Med, J. 2023, 125, 64–74. [Google Scholar] [CrossRef] [PubMed]
  46. Kim, Y.S.; Yuan, J.; Dewar, A.; Borg, J.-P.; Threadgill, D.W.; Sun, X.; Dey, S.K. An unanticipated discourse of HB-EGF with VANGL2 signaling during embryo implantation. Proc. Natl. Acad. Sci. 2023, 120. [Google Scholar] [CrossRef]
  47. Moulder, S.L.; Borges, V.F.; Baetz, T.; Mcspadden, T.; Fernetich, G.; Murthy, R.K.; Chavira, R.; Guthrie, K.; Barrett, E.; Chia, S.K. Phase I Study of ONT-380, a HER2 Inhibitor, in Patients with HER2+-Advanced Solid Tumors, with an Expansion Cohort in HER2+ Metastatic Breast Cancer (MBC). Clin. Cancer Res. 2017, 23, 3529–3536. [Google Scholar] [CrossRef] [PubMed]
  48. Hickinson, D.M.; Klinowska, T.; Speake, G.; Vincent, J.; Trigwell, C.; Anderton, J.; Beck, S.; Marshall, G.; Davenport, S.; Callis, R.; et al. AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer. Clin. Cancer Res. 2010, 16, 1159–1169. [Google Scholar] [CrossRef]
  49. Papa, M.; Mezzogiorno, V.; Bresciani, F.; Weisz, A. Estrogen induces c-fos expression specifically in the luminal and glandular epithelia of adult rat uterus. Biochem. Biophys. Res. Commun. 1991, 175, 480–485. [Google Scholar] [CrossRef]
  50. Whitby, S.; Zhou, W.; Dimitriadis, E. Alterations in Epithelial Cell Polarity During Endometrial Receptivity: A Systematic Review. Front. Endocrinol. 2020, 11, 596324. [Google Scholar] [CrossRef]
  51. Li, Y.; Sun, X.; Dey, S.K. Entosis Allows Timely Elimination of the Luminal Epithelial Barrier for Embryo Implantation. Cell Rep. 2015, 11, 358–365. [Google Scholar] [CrossRef]
  52. Daikoku, T.; Cha, J.; Sun, X.; Tranguch, S.; Xie, H.; Fujita, T.; Hirota, Y.; Lydon, J.; DeMayo, F.; Maxson, R.; et al. Conditional Deletion of MSX Homeobox Genes in the Uterus Inhibits Blastocyst Implantation by Altering Uterine Receptivity. Dev. Cell 2011, 21, 1014–1025. [Google Scholar] [CrossRef]
  53. Sun, X.; Bartos, A.; Whitsett, J.A.; Dey, S.K. Uterine Deletion of Gp130 or Stat3 Shows Implantation Failure with Increased Estrogenic Responses. Mol. Endocrinol. 2013, 27, 1492–1501. [Google Scholar] [CrossRef] [PubMed]
  54. Uetzmann, L.; Burtscher, I.; Lickert, H. A mouse line expressing Foxa2-driven Cre recombinase in node, notochord, floorplate, and endoderm. Genesis 2008, 46, 515–522. [Google Scholar] [CrossRef]
  55. Kelleher, A.M.; Allen, C.C.; Davis, D.J.; Spencer, T.E. Prss29 Cre recombinase mice are useful to study adult uterine gland function. Genesis 2022, 60, e23493. [Google Scholar] [CrossRef] [PubMed]
  56. Filant, J.; Spencer, T.E. Cell-Specific Transcriptional Profiling Reveals Candidate Mechanisms Regulating Development and Function of Uterine Epithelia in Mice. Biol. Reprod. 2013, 89, 86. [Google Scholar] [CrossRef] [PubMed]
  57. Messaoudi, S.; EL Kasmi, I.; Bourdiec, A.; Crespo, K.; Bissonnette, L.; Le Saint, C.; Bissonnette, F.; Kadoch, I.-J. 15 years of transcriptomic analysis on endometrial receptivity: What have we learnt? Fertil. Res. Pr. 2019, 5, 1–9. [Google Scholar] [CrossRef]
  58. Aghajanova, L.; Altmäe, S.; Bjuresten, K.; Hovatta, O.; Landgren, B.-M.; Stavreus-Evers, A. Disturbances in the LIF pathway in the endometrium among women with unexplained infertility. Fertil. Steril. 2009, 91, 2602–2610. [Google Scholar] [CrossRef]
Figure 1. Uterine epithelium-specific deletion of Lifr (Lifr eKO) results in female infertility. (A) Pregnancy outcomes in control and uterine epithelium-specific Lifr (Lifr eKO) females mated to wild-type males. (B) Representative gross morphology of uteri from control and Lifr eKO females on D4 (1600 h) and D5. Implantation sites (indicated by white arrowheads) are visualized through blue dye injection on D5. Hatched blastocysts (shown in the inset) were recovered from the Lifr eKO uterus. Scale bar = 1 cm. (C) Cross-sectional images of uteri on D4 (1600 h). Scale bar = 100 µm. (D) Longitudinal sections of uteri on D5. Scale bar = 100 µm. Arrowheads indicate blastocysts. “A” indicates the distance from the mesometrial edge to the center of the blastocyst. “B” indicates the distance from the mesometrial edge to the anti-mesometrial edge. (E) The depth of the uterine chamber (A/B ratio shown in panel D) is comparable between the control and Lifr eKO females. (F) Immunostaining for CDH1 on D5. Scale bar = 100 µm. Arrowheads indicate blastocysts. (G) Whole-mount staining for CDH1 on D5. Scale bar = 200 µm. Arrowheads indicate blastocysts. (H) Serum levels of progesterone (P4) and 17β-estradiol (E2) on D4.
Figure 1. Uterine epithelium-specific deletion of Lifr (Lifr eKO) results in female infertility. (A) Pregnancy outcomes in control and uterine epithelium-specific Lifr (Lifr eKO) females mated to wild-type males. (B) Representative gross morphology of uteri from control and Lifr eKO females on D4 (1600 h) and D5. Implantation sites (indicated by white arrowheads) are visualized through blue dye injection on D5. Hatched blastocysts (shown in the inset) were recovered from the Lifr eKO uterus. Scale bar = 1 cm. (C) Cross-sectional images of uteri on D4 (1600 h). Scale bar = 100 µm. (D) Longitudinal sections of uteri on D5. Scale bar = 100 µm. Arrowheads indicate blastocysts. “A” indicates the distance from the mesometrial edge to the center of the blastocyst. “B” indicates the distance from the mesometrial edge to the anti-mesometrial edge. (E) The depth of the uterine chamber (A/B ratio shown in panel D) is comparable between the control and Lifr eKO females. (F) Immunostaining for CDH1 on D5. Scale bar = 100 µm. Arrowheads indicate blastocysts. (G) Whole-mount staining for CDH1 on D5. Scale bar = 200 µm. Arrowheads indicate blastocysts. (H) Serum levels of progesterone (P4) and 17β-estradiol (E2) on D4.
Biomolecules 15 00698 g001
Figure 2. Histochemical characterization in the Lifr eKO uterus prior to embryo implantation. (A) Immunostaining for phosphorylated STAT3 (pSTAT3) on D4 (1600 h). Scale bar = 100 µm. (B) Cell proliferation status assessed by MKI67 immunostaining on D4 (1600 h), with the inset showing higher magnification. Scale bar = 100 µm. (C) The expression of estrogen receptor alpha (ESR1) and progesterone receptor (PGR) on D4 (1600 h). Scale bar = 100 µm. (D) The representative gross morphology of uteri after the artificial decidualization of stimuli in control and Lifr eKO mice (upper panels). Scale bar = 1 cm. Red arrows indicate the site of sesame oil injection, and red dashed lines mark the point of sectioning. Immunostaining for MKI67 in uteri (lower panels). Scale bar = 200 µm; inset scale bar = 50 µm.
Figure 2. Histochemical characterization in the Lifr eKO uterus prior to embryo implantation. (A) Immunostaining for phosphorylated STAT3 (pSTAT3) on D4 (1600 h). Scale bar = 100 µm. (B) Cell proliferation status assessed by MKI67 immunostaining on D4 (1600 h), with the inset showing higher magnification. Scale bar = 100 µm. (C) The expression of estrogen receptor alpha (ESR1) and progesterone receptor (PGR) on D4 (1600 h). Scale bar = 100 µm. (D) The representative gross morphology of uteri after the artificial decidualization of stimuli in control and Lifr eKO mice (upper panels). Scale bar = 1 cm. Red arrows indicate the site of sesame oil injection, and red dashed lines mark the point of sectioning. Immunostaining for MKI67 in uteri (lower panels). Scale bar = 200 µm; inset scale bar = 50 µm.
Biomolecules 15 00698 g002
Figure 3. Comprehensive gene expression analysis between control and Lifr eKO uterus before embryo implantation. (A) Heatmap displaying genes with altered expression levels in Lifr eKO uteri (FDR < 0.05). (B) Volcano plot showing differentially expressed genes (DEGs) that are either downregulated or upregulated in Lifr eKO compared to controls. (C,D) Gene ontology (GO) analysis of downregulated (C) and upregulated (D) DEGs in Lifr eKO uteri compared to controls, highlighting systematic characteristics of these genes. (E,F) Venn diagrams illustrating the overlap of downregulated (E) and upregulated (F) DEGs between Lifr eKO and Gp130 eKO uteri.
Figure 3. Comprehensive gene expression analysis between control and Lifr eKO uterus before embryo implantation. (A) Heatmap displaying genes with altered expression levels in Lifr eKO uteri (FDR < 0.05). (B) Volcano plot showing differentially expressed genes (DEGs) that are either downregulated or upregulated in Lifr eKO compared to controls. (C,D) Gene ontology (GO) analysis of downregulated (C) and upregulated (D) DEGs in Lifr eKO uteri compared to controls, highlighting systematic characteristics of these genes. (E,F) Venn diagrams illustrating the overlap of downregulated (E) and upregulated (F) DEGs between Lifr eKO and Gp130 eKO uteri.
Biomolecules 15 00698 g003
Figure 4. ERBB2 signaling is essential for embryo implantation. (A,B) Immunostaining for ERBB2 (A) and c-FOS (B) in the pregnant uterus. Scale bar = 100 µm. Arrowheads indicate blastocysts. (C) The experimental procedure for administering ERBB2 inhibitors to pregnant females. (D) Representative images of gross uterine morphology from control and drug-treated mice. Arrowheads indicate implantation sites. Scale bar = 1 cm. (E) Sapitinib treatment inhibits up to 50% of embryo implantation. (F) A model illustrating LIFR-mediated embryo implantation in mice.
Figure 4. ERBB2 signaling is essential for embryo implantation. (A,B) Immunostaining for ERBB2 (A) and c-FOS (B) in the pregnant uterus. Scale bar = 100 µm. Arrowheads indicate blastocysts. (C) The experimental procedure for administering ERBB2 inhibitors to pregnant females. (D) Representative images of gross uterine morphology from control and drug-treated mice. Arrowheads indicate implantation sites. Scale bar = 1 cm. (E) Sapitinib treatment inhibits up to 50% of embryo implantation. (F) A model illustrating LIFR-mediated embryo implantation in mice.
Biomolecules 15 00698 g004
Table 1. Primary antibody list.
Table 1. Primary antibody list.
TargetSpeciesSourceCatalog No.RRIDDilutionApplication
c-FOSRabbitAbcamab222699AB_28910491:1000IF
ESR1RabbitAbcamab32063AB_7322491:200IHC
PGRRabbitAbcamab101688AB_107152481:200IHC
MKI67RabbitAbcamab16667AB_3024591:200IHC
ERBB2MouseSanta Cruzsc-33684AB_6279961:200IF
CDH1RabbitCell Signaling Technology#3195AB_20666831:200IF
pSTAT3 RabbitCell Signaling Technology#9145AB_24910091:200IHC
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Terakawa, J.; Nakamura, S.; Ohtomo, M.; Uehara, S.; Kawata, Y.; Takarabe, S.; Sugita, H.; Namiki, T.; Kageyama, A.; Noguchi, M.; et al. LIFR-Mediated ERBB2 Signaling Is Essential for Successful Embryo Implantation in Mice. Biomolecules 2025, 15, 698. https://doi.org/10.3390/biom15050698

AMA Style

Terakawa J, Nakamura S, Ohtomo M, Uehara S, Kawata Y, Takarabe S, Sugita H, Namiki T, Kageyama A, Noguchi M, et al. LIFR-Mediated ERBB2 Signaling Is Essential for Successful Embryo Implantation in Mice. Biomolecules. 2025; 15(5):698. https://doi.org/10.3390/biom15050698

Chicago/Turabian Style

Terakawa, Jumpei, Sakura Nakamura, Mana Ohtomo, Saki Uehara, Yui Kawata, Shunsuke Takarabe, Hibiki Sugita, Takafumi Namiki, Atsuko Kageyama, Michiko Noguchi, and et al. 2025. "LIFR-Mediated ERBB2 Signaling Is Essential for Successful Embryo Implantation in Mice" Biomolecules 15, no. 5: 698. https://doi.org/10.3390/biom15050698

APA Style

Terakawa, J., Nakamura, S., Ohtomo, M., Uehara, S., Kawata, Y., Takarabe, S., Sugita, H., Namiki, T., Kageyama, A., Noguchi, M., Murakami, H., Kashiwazaki, N., & Ito, J. (2025). LIFR-Mediated ERBB2 Signaling Is Essential for Successful Embryo Implantation in Mice. Biomolecules, 15(5), 698. https://doi.org/10.3390/biom15050698

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop